Covaxin is developed by Hyderabad-based Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology, Pune (NIV).
The government's vaccination scheme has created two classes of citizens in India those who got Covaxin, whose movements are restricted, and those who received Covishield and can go anywhere.
COVID-19: Bharat Biotech’s Covaxin recognized by Australia for travel purposes - Australia has given approval to Bharat Biotech’s Covaxin for travel purposes in the country, mainly to assist workers and students.
The Therapeutic Goods Administration (TGA) also granted recognition to BBIBP-CorV (manufactured by Sinopharm, China, for the purpose of establishing a traveller's vaccination status.